Effect of Subcutaneous Spesolimab on the Prevention of Generalized Pustular Psoriasis Flares Over 48 Weeks: Subgroup Analyses from the Effisayil 2 Trial . J of Skin 2023, 7 (6), s245. https://doi.org/10.25251/skin.7.supp.245.